Cargando…
Metabolic reprogramming: a bridge between aging and tumorigenesis
Aging is the most robust risk factor for cancer development, with more than 60% of cancers occurring in those aged 60 and above. However, how aging and tumorigenesis are intertwined is poorly understood and a matter of significant debate. Metabolic changes are hallmarks of both aging and tumorigenes...
Autores principales: | Drapela, Stanislav, Ilter, Didem, Gomes, Ana P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490145/ https://www.ncbi.nlm.nih.gov/pubmed/35666002 http://dx.doi.org/10.1002/1878-0261.13261 |
Ejemplares similares
-
NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis
por: Ilter, Didem, et al.
Publicado: (2023) -
Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
por: Shunxi, Wang, et al.
Publicado: (2023) -
Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer
por: Wang, Ting, et al.
Publicado: (2023) -
Altered propionate metabolism contributes to tumor progression and aggressiveness
por: Gomes, Ana P., et al.
Publicado: (2022) -
LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases
por: Zhang, Yanghe, et al.
Publicado: (2020)